arrow
S

Stephen L. Hauser

University of California San Francisco
H指数:91
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neural autoantibodies in the cerebrospinal fluid of individuals with schizophrenia spectrum disorders

精神分裂症谱系障碍患者脑脊液中的神经自身抗体

2026-11-030
OAAI
Cell-specific proteome profiling reveals altered peripheral immune cell communication in early multiple sclerosis

细胞特异性蛋白质组学分析揭示早期多发性硬化中周围免疫细胞通讯的改变

2026-10-170
OAAI
Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis

多发性硬化中克隆富集的CD8 T细胞的抗原特异性

2026-02-050
OAAI
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis

首次使用奥法木单抗作为一线治疗新近诊断且未接受过治疗的复发型多发性硬化患者的6年安全性与有效性结果

2025-11-250
OAAI
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomography

使用光学相干层析成像研究年龄对多发性硬化症中视神经炎后神经退行性变的影响

2025-10-210
OA
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis

多发性硬化症的髓鞘损伤先于轴突损伤和症状发作

2025-10-200
PRE
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis

奥法木单抗在复发型多发性硬化患者中的五年安全性和有效性结局

2025-07-130
OAAI
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis

大剂量脉冲糖皮质激素治疗可预防新诊断多发性硬化患者脊髓白质的假性萎缩

2025-06-240
OAAI
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency

自身免疫性维生素B12中枢缺乏症中的钴胺素受体抗体

2024-06-262
OA
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis

炎性和神经退行性血清蛋白生物标志物可提高对多发性硬化症临床及影像学疾病活动性的检测灵敏度。

2024-05-202
OAAI
Genetic mapping across autoimmune diseases reveals shared associations and mechanisms

跨自身免疫性疾病的遗传图谱揭示了共享的关联和机制

2024-05-132
PRE
An autoantibody signature predictive for multiple sclerosis

多发性硬化症的自身抗体特征预测

2024-04-1912
PRE
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment

开发Ofatumumab,一种用于复发性多发性硬化症治疗的全人Anti-CD20单克隆抗体

2023-07-1413
OAAI